BSEGeneral2d ago · 16 Nov 2026, 03:39 pm

Subsequent Intimation of Bank Deafult in Pursuant to Regulation 30 Para A of SEBI (LODR), 2015

Mangalam Drugs & Organics Ltd · 532637

✦ AI Summary▼ NegativeDebt Restruc.

Mangalam Drugs & Organics Ltd has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of the exchange.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern6/10
Regulatory Risk9/10
Balance Sheet Risk8/10
Liquidity Impact4/10
Market Sentiment2/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mangalam Drugs & Organics Ltd - 532637 - Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure

Attachments (1)

📄

89df784b-1d85-4da8-87b6-608d8367d3bf.pdf

pdf

Download →
View document text
Mangalam Drugs and Organics Limited Regd. Office : R ®u p 9a 1m -Bu 2ild 2in .g, 3r 2d 6F 6l 1o 3o 0r 60, 2/2 3 089 08P. D @' 9M 1el -l 2o -R 6oa 2d 6, 9N 0e 9ar G ». CP, M Lu 24m 2b 3a 0i 4 190 720 C00 11 16413 hMA _NGA _LA dM | REF: MDOL/CS-SE/2026-27/044 November 16", 2026 Listing Department Listing Department BSE Ltd National Stock Exchange of India 1* Floor, New Trade Wing, Limited Phiroze Jecjeebhoy Towers, “Exchange Plaza”, 5" Floor, Dalal Street, Fort, Plot No. C-1, Block G, Mumbai - 400 001 Bandra - Kurla Complex, Bandra(E), Mumbai — 400 051 Serip Code: 532637 Symbol: MANGALAM Subject: Disclosure under Regulation 30, Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 of default on bank loan account Dear Sir/Madam, T'his is with reference to Regulation 30. Part A of Schedule 11l of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 whereby a Listed Entity is required to make disclosure to stock exchange(s) Events which shall be disclosed without any application of the guidelines for materiality as specified in sub-regulation (4) of regulation (30) Part A (6) Default by a Listed Entity non-payment oft he interest or principal amount in full on the date when the debt has become due and payable. Explanation 1: In case of revolving facilities like cash credit, an entity would be considered to be in “default’ if the outstanding balance remains continuously in excess of the sanctioned limit or drawing power, whichever is lower, for more than thirty days. In view of the said provision, Mangalam Drugs and Organics Limited (the Company) is making subsequent intimation declaring that the Company has defaulted on its loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days, as per the regulations of your exchange. As on date, the data is given below: | Sr.No | Loan Account Name of Bank Amount Overdue | Date ofs tart of Number - Cash Rs. In Lacs as on | Default o Credit A/c. No. 15/11/2026 h 60383561246 Bank of Maharashtra 951.19 17/10/2025 2 04170500000243 | Bank of Baroda 606.08 20/10/2025 We are also making arrangements to pay the overdue amount as soon as possible Kindly take the above and attachment provided by management on your records. Thanking You, Yours Faithfully, For Mangalam Drugs & Organics Limited Govardhan M. Dhoot Managing Director DIN: 01240086 Factory : at Vapi (Gujarat) India & contactus: @mangalamdrugs.com @ http://www. mangalamdrugs.com Mangalam Drugs and Organics Limited Regd: Office : Rupam Building, 3rd Floor, 239 P. D’Mello Road, Near G. P. 0. Mumbai - 400 001 ® 91-22-62/6 613060 2/ 807087 ® 91-22-62619090 e CIN : L24230MH1972PLC116413 Accredited | 16/11/2026 The Company Secretary Mangalam Drugs and Organics Ltd. Mumbai. Subject : Disclosure of subsequent default on bank loan account Dear Sir/Madam, eT Lh xti d h el a de st t ne d gr e f 3is a f u u l dr t at yeh sde nt so pio t esu ol hae et n t re o er b lD uit lg. a t1 t i6 i oo/ nn0 ss2 o/ t f2 o 0 2 B o6 ua rna k en xd o o aB nai grn ef o .o d r am ay no du t Bh aa nt k M oa fn g Ma ahl aa rm a sD hru tg rs a a fn ord aO r pg ea rn ii oc ds |\ Sr.No | NL uo man b eA rc c - o Cu an st h | Name of Bank W Amount Overdue Daterofisrtart of N _C 6 r 0e 3d 8i 3t 5A 6/ 1c 2. 4 6N o. | Bank - of Ma harashtr| a Rs. 1 5In 7 9 51L 11a .7c 1s 2 9 0a 2s 6 o n | o 17/De 1 f 0a /u 2l 0t 2 5 ] | 04170500000243 | Bank ofB aroda 606.08 \ 20/10/2025 | L - R Kindly acknowledge the same. Thanking You, For Marigalam Drugs and Organics Ltd., Jeevan Dalvi Chief Financial Officer. Factory : at Vapi (Gujarat) India & contactus@mangalamdrugs.com @ http://www. mangalamdrugs.com